Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient

Full text
Author(s):
Show less -
Alves-Ferreira, Eliza V. C. [1] ; Toledo, Juliano S. [1, 2] ; De Oliveira, Arthur H. C. [3, 1] ; Ferreira, Tiago R. [1] ; Ruy, Patricia C. [1] ; Pinzan, Camila F. [1] ; Santos, Ramon F. [1] ; Boaventura, Viviane [4, 5] ; Rojo, David [2] ; Lopez-Gonzalvez, Angelez [2] ; Rosa, Jose C. [1] ; Barbas, Coral [2] ; Barral-Netto, Manoel [4, 5] ; Barral, Aldina [4, 5] ; Cruz, Angela K. [1]
Total Authors: 15
Affiliation:
[1] Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, Fac Med Ribeirao Preto, Sao Paulo - Brazil
[2] Univ CEU San Pablo, Ctr Metabol & Bioanal CEMBIO, Interacc & Bioanal UMIB, Madrid - Spain
[3] Univ Sao Paulo, Dept Quim, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo - Brazil
[4] Fdn Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, Salvador, BA - Brazil
[5] Univ Fed Bahia, Fac Med, Salvador, BA - Brazil
Total Affiliations: 5
Document type: Journal article
Source: PLoS Neglected Tropical Diseases; v. 9, n. 9 SEP 2015.
Web of Science Citations: 16
Abstract

Background Leishmaniasis is a complex disease in which clinical outcome depends on factors such as parasite species, host genetics and immunity and vector species. In Brazil, Leishmania (Viannia) braziliensis is a major etiological agent of cutaneous (CL) and mucosal leishmaniasis (MCL), a disfiguring form of the disease, which occurs in similar to 10% of L. braziliensis-infected patients. Thus, clinical isolates from patients with CL and MCL may be a relevant source of information to uncover parasite factors contributing to pathogenesis. In this study, we investigated two pairs of L. (V.) braziliensis isolates from mucosal (LbrM) and cutaneous (LbrC) sites of the same patient to identify factors distinguishing parasites that migrate from those that remain at the primary site of infection. Methodology/Principal Findings We observed no major genomic divergences among the clinical isolates by molecular karyotype and genomic sequencing. RT-PCR revealed that the isolates lacked Leishmania RNA virus (LRV). However, the isolates exhibited distinct in vivo pathogenesis in BALB/c mice; the LbrC isolates were more virulent than the LbrM isolates. Metabolomic analysis revealed significantly increased levels of 14 metabolites in LbrC parasites and 31 metabolites in LbrM parasites that were mainly related to inflammation and chemotaxis. A proteome comparative analysis revealed the overexpression of LbrPGF2S (prostaglandin f2-alpha synthase) and HSP70 in both LbrC isolates. Overexpression of LbrPGF2S in LbrC and LbrM promastigotes led to an increase in infected macrophages and the number of amastigotes per cell at 24-48 h post-infection (p.i.). Conclusions/Significance Despite sharing high similarity at the genome structure and ploidy levels, the parasites exhibited divergent expressed genomes. The proteome and metabolome results indicated differential profiles between the cutaneous and mucosal isolates, primarily related to inflammation and chemotaxis. BALB/c infection revealed that the cutaneous isolates were more virulent than the mucosal parasites. Furthermore, our data suggest that the LbrPGF2S protein is a candidate to contribute to parasite virulence profiles in the mammalian host. (AU)

FAPESP's process: 11/02040-4 - The role of Prostaglandin F2-alpha synthase in the interaction of Leishmania braziliensis with the mammalian host
Grantee:Eliza Vanessa Carneiro Alves Ferreira
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 10/20597-3 - Host-parasite interaction: models for studying virulence and tropism
Grantee:Angela Kaysel Cruz
Support Opportunities: Regular Research Grants
FAPESP's process: 09/01641-4 - Comparative analyses of the expressed genome of isolates of Leishmania braziliensis responsible to induce distinct clinical manifestations
Grantee:Eliza Vanessa Carneiro Alves Ferreira
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 06/50323-7 - Control of gene expression and genetlc plasticity in Leishmania
Grantee:Angela Kaysel Cruz
Support Opportunities: Research Projects - Thematic Grants